Moreover, reports that suggested that a loss of CDX2 is an adverse prognostic factor in colorectal cancer employed, in contrast to the current work that was based on mRNA expression, protein analysis by immunohistochemistry [11,40]. The gene discussed is CDX2; the disease is colorectal cancer.